BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

375 related articles for article (PubMed ID: 23433797)

  • 1. Magnetic resonance imaging (MRI) markers for MRI-guided high-dose-rate brachytherapy: novel marker-flange for cervical cancer and marker catheters for prostate cancer.
    Schindel J; Muruganandham M; Pigge FC; Anderson J; Kim Y
    Int J Radiat Oncol Biol Phys; 2013 Jun; 86(2):387-93. PubMed ID: 23433797
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Applicator reconstruction in MRI 3D image-based dose planning of brachytherapy for cervical cancer.
    Haack S; Nielsen SK; Lindegaard JC; Gelineck J; Tanderup K
    Radiother Oncol; 2009 May; 91(2):187-93. PubMed ID: 18977049
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical feasibility of combined intracavitary/interstitial brachytherapy in locally advanced cervical cancer employing MRI with a tandem/ring applicator in situ and virtual preplanning of the interstitial component.
    Fokdal L; Tanderup K; Hokland SB; Røhl L; Pedersen EM; Nielsen SK; Paludan M; Lindegaard JC
    Radiother Oncol; 2013 Apr; 107(1):63-8. PubMed ID: 23452917
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of artifacts and distortions of titanium applicators on 3.0-Tesla MRI: feasibility of titanium applicators in MRI-guided brachytherapy for gynecological cancer.
    Kim Y; Muruganandham M; Modrick JM; Bayouth JE
    Int J Radiat Oncol Biol Phys; 2011 Jul; 80(3):947-55. PubMed ID: 20934275
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of an active magnetic resonance tracking system for interstitial brachytherapy.
    Wang W; Viswanathan AN; Damato AL; Chen Y; Tse Z; Pan L; Tokuda J; Seethamraju RT; Dumoulin CL; Schmidt EJ; Cormack RA
    Med Phys; 2015 Dec; 42(12):7114-21. PubMed ID: 26632065
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel MRI marker for prostate brachytherapy.
    Frank SJ; Stafford RJ; Bankson JA; Li C; Swanson DA; Kudchadker RJ; Martirosyan KS
    Int J Radiat Oncol Biol Phys; 2008 May; 71(1):5-8. PubMed ID: 18406882
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multicentre treatment planning study of MRI-guided brachytherapy for cervical cancer: comparison between tandem-ovoid applicator users.
    Nomden CN; de Leeuw AA; Van Limbergen E; de Brabandere M; Nulens A; Nout RA; Laman M; Ketelaars M; Lutgens L; Reniers B; Jürgenliemk-Schulz IM
    Radiother Oncol; 2013 Apr; 107(1):82-7. PubMed ID: 23127774
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MRI-guided treatment-planning optimisation in intracavitary or combined intracavitary/interstitial PDR brachytherapy using tandem ovoid applicators in locally advanced cervical cancer.
    Jürgenliemk-Schulz IM; Tersteeg RJ; Roesink JM; Bijmolt S; Nomden CN; Moerland MA; de Leeuw AA
    Radiother Oncol; 2009 Nov; 93(2):322-30. PubMed ID: 19748695
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A dose planning study on applicator guided stereotactic IMRT boost in combination with 3D MRI based brachytherapy in locally advanced cervical cancer.
    Assenholt MS; Petersen JB; Nielsen SK; Lindegaard JC; Tanderup K
    Acta Oncol; 2008; 47(7):1337-43. PubMed ID: 18663651
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Image-guided cervix high-dose-rate brachytherapy treatment planning: does custom computed tomography planning for each insertion provide better conformal avoidance of organs at risk?
    Davidson MT; Yuen J; D'Souza DP; Batchelar DL
    Brachytherapy; 2008; 7(1):37-42. PubMed ID: 18299111
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A dose-volume analysis of magnetic resonance imaging-aided high-dose-rate image-based interstitial brachytherapy for uterine cervical cancer.
    Yoshida K; Yamazaki H; Takenaka T; Kotsuma T; Yoshida M; Furuya S; Tanaka E; Uegaki T; Kuriyama K; Matsumoto H; Yamada S; Ban C
    Int J Radiat Oncol Biol Phys; 2010 Jul; 77(3):765-72. PubMed ID: 19836165
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adaptive image guided brachytherapy for cervical cancer: a combined MRI-/CT-planning technique with MRI only at first fraction.
    Nesvacil N; Pötter R; Sturdza A; Hegazy N; Federico M; Kirisits C
    Radiother Oncol; 2013 Apr; 107(1):75-81. PubMed ID: 23068712
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Magnetic resonance imaging-guided intracavitary brachytherapy for cancer of the cervix.
    Zwahlen D; Jezioranski J; Chan P; Haider MA; Cho YB; Yeung I; Levin W; Manchul L; Fyles A; Milosevic M
    Int J Radiat Oncol Biol Phys; 2009 Jul; 74(4):1157-64. PubMed ID: 19101097
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Techniques for and uncertainties of MRI-based reconstruction of titanium tandem and ring brachytherapy applicators.
    Malajovich I; Anamalayil S; Dolney OV; Kevin Teo BK; Arscott WT; Taunk NK
    Brachytherapy; 2020; 19(5):651-658. PubMed ID: 32624406
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anisotropy characterization of I-125 seed with attached encapsulated cobalt chloride complex contrast agent markers for MRI-based prostate brachytherapy.
    Frank SJ; Tailor RC; Kudchadker RJ; Martirosyan KS; Stafford RJ; Elliott AM; Swanson DA; Sing D; Choi J; Mourtada F; Ibbott GS
    Med Dosim; 2011; 36(2):200-5. PubMed ID: 20537886
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dosimetric impact of interfraction catheter movement and organ motion on MRI/CT guided HDR interstitial brachytherapy for gynecologic cancer.
    Rey F; Chang C; Mesina C; Dixit N; Kevin Teo BK; Lin LL
    Radiother Oncol; 2013 Apr; 107(1):112-6. PubMed ID: 23333023
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Validation of a novel robot-assisted 3DUS system for real-time planning and guidance of breast interstitial HDR brachytherapy.
    Poulin E; Gardi L; Barker K; Montreuil J; Fenster A; Beaulieu L
    Med Phys; 2015 Dec; 42(12):6830-9. PubMed ID: 26632040
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Image-guided brachytherapy for cervical cancer: a Canadian Brachytherapy Group survey.
    Pavamani S; D'Souza DP; Portelance L; Craighead PS; Pearce AG; Traptow LL; Doll CM
    Brachytherapy; 2011; 10(5):345-51. PubMed ID: 21345744
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dosimetric impact of contouring and needle reconstruction uncertainties in US-, CT- and MRI-based high-dose-rate prostate brachytherapy treatment planning.
    Rylander S; Buus S; Pedersen EM; Bentzen L; Tanderup K
    Radiother Oncol; 2017 Apr; 123(1):125-132. PubMed ID: 28284493
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of an MR-only interstitial gynecologic brachytherapy workflow using MR-line marker for catheter reconstruction.
    Shaaer A; Paudel M; Smith M; Tonolete F; Nicolae A; Leung E; Ravi A
    Brachytherapy; 2020; 19(5):642-650. PubMed ID: 32712027
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.